News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
244,919 Results
Type
Article (5885)
Company Profile (20)
Press Release (239014)
Section
Business (87673)
Career Advice (470)
Deals (16481)
Drug Delivery (9)
Drug Development (21289)
Employer Resources (32)
FDA (4053)
Job Trends (4549)
News (129805)
Policy (8421)
Tag
2024 BioCapital Digital (2)
2024 Biotech Beach Standard (1)
2024 Pharm Country Digital (2)
2025 Lone Star Bio Digital (1)
Academia (337)
Accelerated approval (2)
Adcomms (4)
Allergies (9)
Alliances (16193)
ALS (20)
Alzheimer's disease (317)
Antibody-drug conjugate (ADC) (14)
Approvals (4073)
Artificial intelligence (46)
Autoimmune disease (5)
Automation (2)
Bankruptcy (107)
Best Places to Work (3389)
Biosimilars (12)
Biotechnology (28)
Bladder cancer (11)
Brain cancer (8)
Breast cancer (69)
Cancer (503)
Cardiovascular disease (25)
Career advice (401)
Career pathing (2)
CAR-T (32)
Cell therapy (107)
Cervical cancer (2)
Clinical research (17802)
Collaboration (186)
Compensation (164)
Complete response letters (3)
COVID-19 (452)
CRISPR (7)
C-suite (103)
Cystic fibrosis (17)
Data (571)
Depression (7)
Diabetes (46)
Diagnostics (2255)
Digital health (3)
Diversity, equity & inclusion (13)
Drug discovery (26)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (12)
Earnings (42759)
Editorial (2)
Employer branding (6)
Employer resources (33)
Events (40469)
Executive appointments (322)
FDA (4318)
Featured Employer (6)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (220)
Gene editing (16)
Generative AI (2)
Gene therapy (50)
GLP-1 (126)
Government (510)
Guidances (16)
Healthcare (5566)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (472)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (57)
IPO (8407)
IRA (3)
Job creations (1257)
Job search strategy (365)
Kidney cancer (6)
Labor market (4)
Layoffs (109)
Leadership (5)
Legal (2672)
Liver cancer (17)
Lung cancer (57)
Lymphoma (30)
Management (11)
Manufacturing (53)
MASH (27)
Medical device (4301)
Medtech (4303)
Mergers & acquisitions (8306)
Metabolic disorders (125)
Multiple sclerosis (12)
NASH (6)
Neurodegenerative disease (10)
Neuropsychiatric disorders (2)
Neuroscience (422)
NextGen: Class of 2025 (1793)
Non-profit (793)
Northern California (922)
Now hiring (2)
Obesity (53)
Opinion (31)
Ovarian cancer (17)
Pain (15)
Pancreatic cancer (20)
Parkinson's disease (27)
Partnered (8)
Patents (27)
Patient recruitment (28)
Peanut (5)
People (26411)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5271)
Phase II (7851)
Phase III (6135)
Pipeline (557)
Policy (8)
Postmarket research (658)
Preclinical (2090)
Press Release (67)
Prostate cancer (29)
Psychedelics (6)
Radiopharmaceuticals (120)
Rare diseases (74)
Real estate (2013)
Recruiting (9)
Regulatory (5649)
Reports (15)
Research institute (350)
Resumes & cover letters (68)
Rett syndrome (3)
RSV (1)
Schizophrenia (25)
Series A (27)
Series B (22)
Service/supplier (2)
Sickle cell disease (8)
Southern California (701)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (4)
Startups (1123)
State (1)
Stomach cancer (1)
Supply chain (12)
Tariffs (3)
United States (7445)
Vaccines (59)
Venture capitalists (3)
Weight loss (20)
Women's health (1)
Date
Today (8)
Last 7 days (139)
Last 30 days (822)
Last 365 days (11186)
2025 (3142)
2024 (12221)
2023 (14522)
2022 (20432)
2021 (21855)
2020 (19711)
2019 (14319)
2018 (11021)
2017 (10891)
2016 (10005)
2015 (13164)
2014 (10359)
2013 (8349)
2012 (9039)
2011 (9446)
2010 (9259)
Location
Africa (199)
Alabama (14)
Alaska (2)
Arizona (66)
Arkansas (1)
Asia (12161)
Australia (1668)
California (1946)
Canada (1066)
China (76)
Colorado (88)
Connecticut (96)
Delaware (34)
Europe (26012)
Florida (278)
Georgia (38)
Idaho (23)
Illinois (115)
India (6)
Indiana (78)
Iowa (1)
Japan (73)
Kansas (25)
Kentucky (11)
Louisiana (5)
Maine (40)
Maryland (219)
Massachusetts (1599)
Michigan (105)
Minnesota (144)
Mississippi (1)
Missouri (21)
Montana (16)
Nebraska (14)
Nevada (26)
New Hampshire (23)
New Jersey (689)
New Mexico (8)
New York (517)
North Carolina (346)
North Dakota (2)
Northern California (922)
Ohio (56)
Oklahoma (7)
Oregon (3)
Pennsylvania (373)
Puerto Rico (2)
Rhode Island (12)
South America (307)
South Carolina (4)
Southern California (701)
Tennessee (42)
Texas (266)
Utah (62)
Virginia (43)
Washington D.C. (9)
Washington State (176)
West Virginia (2)
Wisconsin (31)
244,919 Results for "genfit corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT Announces 2025 Financial Calendar
January 30, 2025
·
5 min read
Press Releases
GENFIT Announces Revenues and Cash Position as of December 31, 2024
February 28, 2025
·
8 min read
FDA
Ipsen, Genfit’s Elafibranor Wins FDA Approval for Primary Biliary Cholangitis
Ipsen and Genfit’s elafibranor will now be marketed as Iqirvo and is the first new medicine approved in nearly a decade for the treatment of the rare liver disease, according to the companies.
June 11, 2024
·
2 min read
·
Tristan Manalac
Press Releases
GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders
March 21, 2025
·
9 min read
Press Releases
GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
February 10, 2025
·
9 min read
Press Releases
GENFIT Announces Non-Dilutive Royalty Financing Agreement and Debt Overhang Resolution Plan
January 30, 2025
·
17 min read
Press Releases
GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
November 14, 2024
·
14 min read
Press Releases
GENFIT Outlines Anticipated New Clinical Trial Initiations, Development Milestones and Data Readouts in 2025
February 7, 2025
·
9 min read
Genetown
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today detailed its presence at the EASL Congress™ 2024.
May 29, 2024
·
8 min read
Business
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced annual financial results for the year ended December 31, 2023.
April 4, 2024
·
23 min read
1 of 24,492
Next
